Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Khaled Musallam: De-LIGHT Study Reveals Age-Related Multisystem Morbidity in β-Thalassemia
Oct 2, 2026, 11:26

Khaled Musallam: De-LIGHT Study Reveals Age-Related Multisystem Morbidity in β-Thalassemia

Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Haematologica, adding:

“Pleased to share our new study out today in Haematologica:

‘β-thalassemia as a progressive disease: age-related morbidity in the de-LIGHT study.’

Our findings highlight an important shift in how we think about β-thalassemia: as patients live longer, multisystem morbidity progressively accumulates across the lifespan, in both transfusion-dependent and non-transfusion-dependent disease.

These data reinforce the importance of lifelong disease control, age-adapted surveillance, and (hopefully when available) earlier use of disease-modifying approaches before irreversible complications develop.”

Title: β-thalassemia as a progressive disease: age-related morbidity in the de-LIGHT study

Authors: Khaled M. Musallam, Angela Vitrano, Alessandro Inzerillo, Rosario Di Maggio, Rita Barone, Antonino Giangreco, Maria Concetta Renda, Emanuela Fecarotta, Antonio Troia, Antonino Giambona, Giovan Battista Ruffo, Efthymia Vlachaki, Theodora M. Venou, Paolo Ricchi, Brunella Ziello, Marilena Serra, Elena Colizzi, Filomena Longo, Martina Culcasi, Aurelio Maggio

Khaled Musallam

 

Find more posts featuring Khaled Musallam on Hemostasis Today.